e-ISSN: Pending
Failed Experiment ReportOpen accessOphthalmology

CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic Retinopathy

Beatriz G. Armendariz, PhD; Ulrich F.O. Luhman, PhD; Brian Berger, MD; Jules Hernandez-Sanchez, PhD; Katrijn Bogman, PhD; Nikolaos Mitrousis, PhD; Martina Wollenhaupt, MD; David Kent, MD · 2025 · Ophthalmology Science

WASTE classifies this as Failed Experiment Report · AI classification, approximate

An experimental approach did not work as intended — learn what to avoid before investing the same effort.

Abstract

Objective: Nonproliferative diabetic retinopathy (NPDR) is a progressive disease that can lead to blindness. Current therapies for NPDR are invasive and not extensively used or accessible until the disease progresses, pointing to the need for an early noninvasive treatment. The objective of CANBERRA was to assess the safety, tolerability, and efficacy of oral administration of vicasinabin (RG7774) on the severity of diabetic retinopathy (DR) in participants with moderately severe to severe NPDR and good vision. Design: CANBERRA was a global, multicentric randomized, double-masked, parallel-gro

Abstract by Beatriz G. Armendariz, PhD; Ulrich F.O. Luhman, PhD; Brian Berger, MD; Jules Hernandez-Sanchez, PhD; Katrijn Bogman, PhD; Nikolaos Mitrousis, PhD; Martina Wollenhaupt, MD; David Kent, MD, Ophthalmology Science (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1016/j.xops.2024.100650